Aarey Drugs & Pharmaceuticals Limited (BOM:524412)

India flag India · Delayed Price · Currency is INR
69.20
-1.28 (-1.82%)
At close: Mar 9, 2026
70.61%
Market Cap 1.97B
Revenue (ttm) 3.91B
Net Income (ttm) 34.35M
Shares Out 28.45M
EPS (ttm) 1.19
PE Ratio 57.97
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 131
Average Volume 7,411
Open 70.00
Previous Close 70.48
Day's Range 66.88 - 70.00
52-Week Range 31.30 - 100.00
Beta 0.52
RSI 47.84
Earnings Date Feb 11, 2026

About BOM:524412

Aarey Drugs & Pharmaceuticals Limited manufactures and sells active pharmaceutical ingredients, intermediates, and specialty chemicals for various industrial applications in India. The company offers intermediates, including mono methyl urea, di methyl urea, ortho para nitro anisole, 2-bromomethyl-1,3-dioxolane, and uracil. It also provides active pharmaceutical ingredients, such as metformin HCl, mefenamic acid, and doxofylline. In addition, the company trades chemicals and solvents, including aromatic chemicals, chemical acids, chlor-alkali, ... [Read more]

Industry Medicinal Chemicals and Botanical Products
Founded 1990
Employees 132
Stock Exchange Bombay Stock Exchange
Ticker Symbol 524412
Full Company Profile

Financial Performance

In fiscal year 2025, BOM:524412's revenue was 4.74 billion, an increase of 17.73% compared to the previous year's 4.03 billion. Earnings were 40.24 million, a decrease of -14.09%.

Financial Statements

News

There is no news available yet.